Angiodynamics (ANGO) Enterprise Value (2010 - 2026)
Angiodynamics (ANGO) posted Enterprise Value of -$53.9 million for Q2 2026, down 42.46% on a QoQ basis from -$37.8 million in Q1 2026, and up 3.63% year-over-year from -$52.0 million in Q2 2025.
Angiodynamics (ANGO) Enterprise Value (2010 - 2026) Analysis & Trends
Angiodynamics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$53.9 million for Q2 2026.
- Quarterly Enterprise Value rose 3.63% year-over-year to -$53.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$53.9 million (up 3.63% YoY) and the FY2026 annual result came in at -$53.9 million, up 3.63% from the prior year.
- Enterprise Value was -$53.9 million for Q2 2026 at Angiodynamics, down from -$37.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$23.9 million in Q1 2022 and bottomed at -$78.5 million in Q1 2024.
- A 5-year average of -$46.5 million and a median of -$44.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 56.14% — and 2024, when it plunged 160.54%.
- Angiodynamics' Enterprise Value stood at -$29.9 million in 2022, then plunged by 103.96% to -$60.9 million in 2023, then increased by 11.18% to -$54.1 million in 2024, then increased by 23.02% to -$41.6 million in 2025, then retreated by 29.36% to -$53.9 million in 2026.
- Business Quant data shows ANGO's Enterprise Value at -$53.9 million in Q2 2026, -$37.8 million in Q1 2026, and -$41.6 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -1.66 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -5.09 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -816.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -138.60 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -1.06 Bn |
| 10 | Angiodynamics | 558.11 Mn | 504.25 Mn | 46.77 Mn | -53.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -53.86 Mn |
| Feb 28, 2026 | -37.81 Mn |
| Nov 30, 2025 | -41.64 Mn |
| Aug 31, 2025 | -38.76 Mn |
| May 31, 2025 | -55.89 Mn |
| Feb 28, 2025 | -44.76 Mn |
| Nov 30, 2024 | -54.09 Mn |
| Aug 31, 2024 | -55.01 Mn |
| May 31, 2024 | -76.06 Mn |
| Feb 29, 2024 | -78.45 Mn |
| Nov 30, 2023 | -60.90 Mn |
| Aug 31, 2023 | -57.59 Mn |
| May 31, 2023 | -44.62 Mn |
| Feb 28, 2023 | -30.11 Mn |
| Nov 30, 2022 | -29.86 Mn |
| Aug 31, 2022 | -24.56 Mn |
| May 31, 2022 | -28.83 Mn |
| Feb 28, 2022 | -23.89 Mn |
| Nov 30, 2021 | -34.29 Mn |
| Aug 31, 2021 | -35.47 Mn |